Outcomes of endovascular treatment for stenosis occurring after cephalic vein transposition and graft interposition
- Authors
- Jeong, Jewon; Kim, Yong Jae; Goo, Dong Erk
- Issue Date
- Jul-2022
- Publisher
- Elsevier Inc.
- Keywords
- Cephalic arch stenosis; Angioplasty; Arteriovenous fistula; Transposition
- Citation
- Journal of Vascular Surgery: Venous and Lymphatic Disorders, v.10, no.4, pp 916 - 921
- Pages
- 6
- Journal Title
- Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Volume
- 10
- Number
- 4
- Start Page
- 916
- End Page
- 921
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/21165
- DOI
- 10.1016/j.jvsv.2022.01.001
- ISSN
- 2213-333X
- Abstract
- Objective: To evaluate the outcome of endovascular treatment after surgical treatment for cephalic arch stenosis (CAS) in the brachiocephalic fistula (BCF) and to analyze the factors influencing patency. Methods: We conducted a retrospective review of patients undergoing cephalic vein transposition (CVT) or graft interposition (GIP) for CAS from January 1, 2017, to December 31, 2019. A total of 73 patients with restenosis were included in this study. Patients were classified into cephalic transposition (BCF-CVT) (n = 49) and graft interposition (BCF-GIP) (n = 24) groups. We calculated the postintervention primary and secondary patency of endovascular treatment by using the Kaplan-Meier analysis and analyzed variables associated with loss of postintervention patency. Results: Six-month and 12-month postintervention primary patency rates of endovascular treatment for restenosis were 56.7% and 15.6% and secondary patency rates were 89.7% and 72.1%, respectively. In the BCF-CVT group, 6-month and 12-month postintervention primary patency was 56.8% and 17.6% and secondary patency was 93.3% and 79.4%, respectively. In the BCF-GIP group, 6-month and 12-month postintervention primary patency was 56.5% and 8.7% and secondary patency was 85.7% and 56.3%, respectively. There was no significant difference in postintervention primary patency between the two groups (P= .79). However, the BCF-CVT group demonstrated higher postintervention secondary patency (P= .034). The BCF-GIP group had a higher number of stenosis sites (P< .01). There was no significant predictor of reduced postintervention primary patency. The only adverse variable of postintervention secondary patency was BCF-GIP (hazard ratio, 3.14; 95% CI, 1.06-9.34; P < .05). Conclusions: Endovascular treatment is still the acceptable option for stenosis occurring after surgical treatment for CAS. CVT provides higher postintervention secondary patency than GIP.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Radiology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/21165)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.